Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We proposed a new grading and staging system for primary biliary cirrhosis (PBC), which takes into account the degree of both chronic cholangitis activity (CA) and hepatitic activity (HA) for grading disease activity and that of fibrosis, bile duct loss, and chronic cholestasis for staging. In this study, we validated our new system. METHODS: Using liver biopsy specimens from 166 cases of PBC, chronic cholangitis with mild periductal lymphoplasmacytic infiltration, including chronic nonsuppurative destructive cholangitis, and the combined activity of interface hepatitis and lobular hepatitis were categorized into 4 grades on the basis of their degree and distribution (CA0-3 and HA0-3, respectively). For staging, because orcein staining was not available in this study, 2 criteria (fibrosis and bile duct loss) were independently scored from 0 to 3 on the basis of their degrees, and a final stage score was created from the sum. RESULTS: Although there was a relatively uniform distribution of CA0/1/2/3 cases, the cases of HA0/1/2/3 were distributed as 21%, 64%, 13%, and 3%, respectively, with a prominent number of cases categorized as having none or mild HA. The distribution of stages 1 to 4 using our system was considerably different from that using the classic system and, importantly, showed a correlation with patient outcome. CONCLUSIONS: Our system revealed that the activities of chronic cholangitis and hepatitis did not correlate with each other in terms of degree and that our staging system properly reflected the outcome of PBC patients. The present study could validate the effectiveness of this new system for characterizing the pathologic condition of PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A new staging system for PBC was recently proposed, based on the assessment of chronic cholangitis and hepatitis activity [58][59][60].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [59]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This approach identifies four different stages by attributing a score of 0-3 to three histologic components: fibrosis, bile duct loss and deposition of orcein-positive granules.”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A total score of 0 identifies stage 1 (no or minimal progression), 1-3 identifies stage 2 (mild progression), 4-6 identifies stage 3 (moderate progression), and 7-9 identifies stage 4 (advanced progression).”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 1×
“In the majority of chronic liver diseases such as chronic viral hepatitis, the degree of fibrosis constitutes the basis for staging.(5,20,21) However, because cholestasis, in addition to fibrosis, is also a major causative factor of liver failure in PBC,(3,4,22,23) liver transplantation cases of non-cirrhotic livers (…”
BackgroundNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“In the majority of chronic liver diseases such as chronic viral hepatitis, the degree of fibrosis constitutes the basis for staging.(5,20,21) However, because cholestasis, in addition to fibrosis, is also a major causative factor of liver failure in PBC,(3,4,22,23) liver transplantation cases of non-cirrhotic livers (…”
BackgroundClassification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593 · cited 1×
“In the majority of chronic liver diseases such as chronic viral hepatitis, the degree of fibrosis constitutes the basis for staging.(5,20,21) However, because cholestasis, in addition to fibrosis, is also a major causative factor of liver failure in PBC,(3,4,22,23) liver transplantation cases of non-cirrhotic livers (…”
BackgroundKaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753 · cited 1×
“,(6) Scheuer,(7,8) Popper and Schaffner,(9) and Ludwig et al.(10) have been used since the 1960’s.”
MethodSymposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
(1959) · Postgraduate Medical Journal · doi:10.1136/pgmj.45.522.305-d · Cited by 497
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.
Rubin, E., Schaffner, F., & Pópper, H. (1965) · PubMed Central · Cited by 374
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Current understanding of primary biliary cholangitis
Tanaka, A. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 158
“Overall survival was stratified better with Nakanuma’s classification than with the classic system.(82) TREATMENT”
MethodYou, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
“The novel criteria for histology could stratify the risk for PBC progression and outcomes [93, 94].”
BackgroundAutoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
Sarcognato, S., Sacchi, D., Grillo, F., Cazzagon, N., Fabris, L., Cadamuro, M., Cataldo, I., Covelli, C., Mangia, A., & Guido, M. (2021) · Pathologica · doi:10.32074/1591-951x-245 · Cited by 141
Sun, C., Xiao, X., Yan, L., Sheng, L., Wang, Q., Jiang, P., Lian, M., Li, Y., Wei, Y., Zhang, J., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.01.005 · Cited by 66
John, B. V., Khakoo, N. S., Schwartz, K. B., Aitchenson, G., Levy, C., Dahman, B. A., Deng, Y., Goldberg, D. S., Martin, P. B., Kaplan, D. E., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001280 · Cited by 49
“Regardless of response to UDCA, advanced fibrosis is an independent predictor of clinical outcomes, as demonstrated by studies using the Nakanuma histological scoring system (12,16).”
ResultCazzagon, N., Sarcognato, S., Floreani, A., Corrà, G., Martin, S. D., Guzzardo, V., Russo, F. P., & Guido, M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100286 · Cited by 51
“For stage assessment, we applied the 2-criteria method and evaluated the presence and extent of fibrosis and bile duct loss (BDL), excluding the evaluation of orcein-positive granules, since it is nonessential to obtain an accurate and reproducible staging.(17) In addition, DR and metaplastic hepatocytes (MH) were ass…”
Methodde Vries, E., Mazzetti, M., Takkenberg, B., Mostafavi, N., Bikker, H., Marzioni, M., de Veer, R., van der Meer, A., Doukas, M., Verheij, J., et al. (2020) · Liver International · doi:10.1111/liv.14662 · Cited by 37
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
You, H., Duan, W., Li, S., Lv, T., Chen, S., Lu, L., Ma, X., Han, Y., Nan, Y., Xu, X., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00347 · Cited by 46
Seki, A., Ikeda, F., Miyatake, H., Takaguchi, K., Hayashi, S., Osawa, T., Fujioka, S., Tanaka, R., Ando, M., Seki, H., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13746 · Cited by 37
“,((7)) which is based on PBC-specific histological findings including fibrosis, bile duct loss, orcein-positive granules in the liver, cholangitis, and hepatitis.”
BackgroundKobayashi, M., Kakuda, Y., Harada, K., Sato, Y., Sasaki, M., Ikeda, H., Terada, M., Mukai, M., Kaneko, S., & Nakanuma, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3597 · Cited by 34
Recent advances in the diagnosis and treatment of primary biliary cholangitis
Huang, Y.-Q. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i33.1419 · Cited by 31
Primary biliary cirrhosis: proposal for a new simple histological scoring system
Wendum, D., Boëlle, P., Bédossa, P., Zafrani, E., Charlotte, F., Saint‐Paul, M., Michalak, S., Chazouillères, O., & Corpechot, C. (2014) · Liver International · doi:10.1111/liv.12620 · Cited by 28
“The staging of this system was shown to correlate with the patients’ outcome (25).”
ResultLiver fibrosis progression predicts survival in patients with primary biliary cirrhosis
Namisaki, T., Moriya, K., Noguchi, R., Kitade, M., Kawaratani, H., Yamao, J., Mitoro, A., Yoshida, M., Sawai, M., Uejima, M., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12746 · Cited by 23
Primary Sclerosing Cholangitis: Diagnostic Criteria
Cazzagon, N., Sarcognato, S., Catanzaro, E., Bonaiuto, E., Peviani, M., Pezzato, F., & Motta, R. (2024) · Tomography · doi:10.3390/tomography10010005 · Cited by 26
Role of liver biopsy in autoimmune liver disease
Hübscher, S. G. (2014) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2014.01.009 · Cited by 13
Namisaki, T., Moriya, K., Kitade, M., Kawaratani, H., Takeda, K., Okura, Y., Takaya, H., Nishimura, N., Seki, K., Kaji, K., et al. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000765 · Cited by 14
Namisaki, T., Fujinaga, Y., Moriya, K., & Yoshiji, H. (2021) · Hepatology Research · doi:10.1111/hepr.13593 · Cited by 12
Risk Stratification in Primary Biliary Cholangitis
Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175713 · Cited by 14
“proposed a novel approach to histological disease staging (Nakanuma staging system), introducing the concept of PBC grading, which evaluates cholangitis activity and hepatitis activity, and determines the stage of disease based on the presence of fibrosis, orcein-positive granule deposition, and bile duct loss [85].”
MethodJensen, A. H., Ytting, H., Werge, M. P., Rashu, E. B., Hetland, L. E., Thing, M., Nabilou, P., Burisch, J. M., Bojsen-Møller, K. N., Junker, A. E., et al. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00047.2024 · Cited by 11
Papamichalis, P. A., Zachou, K., Papamichali, R., Ιωάννου, Μ., Gatselis, N., Dalekos, G. N., & Koukoulis, G. Κ. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0008 · Cited by 8
Yamashiki, N., Haga, H., Ueda, Y., Ito, T., Yagi, S., Kamo, N., Hata, K., Mori, A., Kaido, T., Okajima, H., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13476 · Cited by 8
Wang, Z., Jin, R., Hao, M., Xie, Y., Liu, Z.-C., Wang, X., & Feng, B. (2022) · Medicine · doi:10.1097/md.0000000000031395 · Cited by 7
Histological evaluation in biliary diseases
Saffioti, F., Motta, R. V., & Quaglia, A. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000908 · Cited by 5
“Of note, five of these components were included in the PSC-adapted Nakanuma system [7,22], with ductular reaction, portal inflammation and portal oedema exclusive to the PSC-histoscore.”
Practical Guide, Challenges, and Pitfalls in Liver Fibrosis Staging
Matsukuma, K. E., & Yeh, M. M. (2023) · Surgical pathology clinics · doi:10.1016/j.path.2023.04.002 · Cited by 6
[Guidelines on the diagnosis and management of primary biliary cholangitis (2021)].
(2021) · PubMed Central · doi:10.3760/cma.j.cn112138-20211112-00794 · Cited by 8
Morphological aspects of small-duct cholangiopathies: A minireview
Sticová, E., & Fabián, O. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i4.538 · Cited by 5
Shi, H., Wang, Q., Liu, H., Xu, B., Liu, Y., Zhao, J., Sun, L., Chen, D., Huang, C., & Jin, R. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0979 · Cited by 7
Histological Findings of Autoimmune Hepatitis
Harada, K. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_4 · Cited by 4
“for HA score 0 or 1, 1 point for HA score 2, and 2 points for HA score 3 [18, 38, 39].”
BackgroundSelf-citationOkumura, T., Kimura, T., Iwadare, T., Wakabayashi, S., Kobayashi, H., Yamashita, Y., Joshita, S., Komatsu, M., Tanaka, N., Matsumoto, A., et al. (2025) · Hepatology Research · doi:10.1111/hepr.70018 · Cited by 3
“Experienced pathologist (KH) reviewed the samples while blinded to clinicopathological data and assigned grading according to the Nakanuma histologic staging and grading system [7, 8].”
Self-citationHarada, K., Kakuda, Y., Tanaka, A., Abe, M., Namisaki, T., Shimoda, S., Zeniya, M., Ido, A., Yoshiji, H., Ohira, H., et al. (2025) · Human Pathology · doi:10.1016/j.humpath.2025.105957 · Cited by 2
Self-citationRomeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 3
“…fibrosis, bile duct loss, and deposition of orcein-positive granules, has demonstrated a superior prognostic ability and correlation with clinical outcomes/treatment failure, thanks to the introduction of the concept of PBC grading, evaluating cholangitis activity and hepatitis activity [180–182].”
Tanaka, A., Leung, P. S. C., Bowlus, C. L., & Gershwin, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_22 · Cited by 2
Tanaka, A., & Gershwin, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00058-0 · Cited by 2
Zen, Y., Hübscher, S. G., & Nakanuma, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00009-0 · Cited by 3
Self-citationAmano, N., Ikeda, Y., Hayashida, S., Takahashi, S., Sato, S., Murata, A., Tsuzura, H., Sato, S., Shimada, Y., Iijima, K., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13434 · Cited by 3
Levy, C., Carrion, A. F., & Mayo, M. J. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch21 · Cited by 2
Trivella, J. P., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00018-3 · Cited by 1
Carey, E. J., & Levy, C. (2018) · Clinics in Liver Disease · doi:10.1016/s1089-3261(18)30044-8 · Cited by 1
Primarni bilijarni kolangitis – prikaz slučaja i pregled literature
Mikolašević, I., & Skenderević, N. (2020) · Hrčak Portal of scientific journals of Croatia (University Computing Centre)
The Pathologist’s Approach to Reviewing Liver Histology
Harada, K. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_10
Self-citationChallenges for diagnosis and treatment of primary biliary cholangitis
Tanaka, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85389-7.00007-7
Khakoo, N. S., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00039-4
Qasim, B., Kumari, H., Kashif, S. N., Abbas, S. M. I., Hani, O., Salma, O., Sauleh, A., Adnan, F., Ali, M., Raheem, A., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00464-6
“This revised classification has demonstrated improved prognostic accuracy in stratifying overall survival [55].”
Histologische Diagnostik von Fibrose und Zirrhose
Longerich, T. (2025) · Springer eBooks · doi:10.1007/978-3-662-70167-6_5
Диба, М. Б., Zadorozhnaya, T. D., & Березенко, В. С. (2025) · Modern pediatrics Ukraine · doi:10.15574/sp.2025.5(149).2026
New Histological Staging and Grading System for Primary Biliary Cirrhosis
Kakuda, Y., Harada, K., & Nakanuma, Y. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_16
“[27]) 16 New Histological Staging and Grading System for Primary Biliary Cirrhosis 221”
BackgroundSelf-citationДиба, М. Б., Березенко, В. С., & Задорожна, Т. Д. (2025) · Paediatric Surgery Ukraine · doi:10.15574/ps.2025.3(88).4756
Диба, М. Б., Березенко, В. С., & Задорожна, Т. Д. (2025) · Modern pediatrics Ukraine · doi:10.15574/sp.2025.7(151).4656
Huang, L.-X., & Feng, B. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i4.318
Metadata
- Authors
- Harada, K., Hsu, M., Ikeda, H., Zeniya, M., & Nakanuma, Y.
- Affiliations
- Kanazawa University (JP)
- Kanazawa University Hospital (JP)
- Jikei University School of Medicine (JP)
- Corresponding author
- Harada, Kenichi
- Hsu, Maylee
- Nakanuma, Yasuni
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2013-02
- Volume
- 47
- Issue
- 2
- Pages
- 174-181
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2036439745
- Semantic Scholar
- 52034f59212a2f355eaf036649aa16c18cee1f2a
- Cited by
- 46
- References
- 26
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 1 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 3 · 2014: 5
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) (submittedVersion, cc-by-nc-nd)
- Funders
- Medical Center, University of Pittsburgh
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- primary biliary cirrhosis, histologic staging, histologic grading, interface hepatitis, liver fibrosis, bile duct loss, disease activity, patient outcomes
- MeSH terms
- Bile Ducts, Biopsy, Cholangitis, Female, Humans, Liver, Liver Cirrhosis, Biliary, Male, Middle Aged, Predictive Value of Tests, Prognosis, Severity of Illness Index, Time Factors, Reproducibility of Results, Disease Progression, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.